Treatment interruptions may occur due to medication shortages, side effects, surgical procedures, financial constraints, or personal circumstances
After considering these alternative options, we proposed that the lookback period for the median allowed amount, 10th and 90th percentile allowed amounts, and count of allowed amounts (discussed in a later section) be based on EDI 835 ERA transaction data from no longer than 12 months prior to posting the MRF
Unlike other Wegovy doses, however, 7.2mg comes in single-dose pens that are disposed of after every use
Food and Drug Administration (FDA)-approved GLP-1 semaglutide and tirzepatide products), as they have been removed from the FDAs shortage list
The announcement may attract attention from both consumers seeking affordable options and investors monitoring shifts in the healthcare sector